Difference between revisions of "Part:BBa K3183201"
(16 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K3183201 short</partinfo> | <partinfo>BBa_K3183201 short</partinfo> | ||
− | |||
<br><br> | <br><br> | ||
− | This part contains CD27L fused to an N-Terminal 6-His Tag and SpyTag for purification, oligomerisation, and other SpyCatcher applications. This endolysin has previously been shown to be specific to <i>C. difficile</i>. This endolysin works by cleaving | + | This part contains CD27L fused to an N-Terminal 6-His Tag and SpyTag for purification, oligomerisation, and other SpyCatcher applications. This endolysin has previously been shown to be specific to <i>C. difficile</i>. This endolysin works by cleaving the bond between N-acetylmuramic acid and L-alanine<sup>1</sup> (Fig. 1), breaking the cell's peptidoglycan and compromising the structural integrity of its cell wall. Two X-ray crystal structures were solved for the N-terminal domain<sup>2</sup>. |
− | [[File: | + | [[File:BBa K3183012 Reaction.png|thumb|right|430px|'''Figure 2:''' X-ray Crystal Structure of the CD27L N-terminal domain (PDB codes 3QAY]] |
<br><br><br><br> | <br><br><br><br> | ||
[[File:BBa_K3183009_Reaction.png|thumb|left|430px|'''Figure 1:''' CD27L Catalytic Reaction.]] | [[File:BBa_K3183009_Reaction.png|thumb|left|430px|'''Figure 1:''' CD27L Catalytic Reaction.]] | ||
<br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br> | ||
− | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
Line 23: | Line 21: | ||
<partinfo>BBa_K3183201 parameters</partinfo> | <partinfo>BBa_K3183201 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
+ | |||
+ | |||
+ | ===Characterisation=== | ||
+ | We expressed endolysin in the pET28A vector following difficulties with Dundee's CD27L<sub>1-179</sub> endolysin [https://parts.igem.org/BBa_K895005 BBa_K895005.] We were able to achieve strong expression under the pET28A system (Fig. 3). | ||
+ | |||
+ | [[File:BBa K31830012 Purification Gel.png|thumb|center|700px|'''Figure 3:''' Fig. 2: SDS-PAGE Protein Purification Gel of CD27L<sub>1-179</sub> using Ni-NTA Affinity Chromatography.]] | ||
+ | |||
+ | Due to safety concerns, our endolysin killing assays could only be carried out on on <i>Bacillus subitlis</i>, a Category 1 bacteria as opposed to Clostridium difficile, a Category 2 bacteria. <i>B. subtilis</i> has a similar composition of peptidogylcan cell wall to C. difficile<sup>2</sup>, allowing us to quantify killing data. We wanted to see if the truncated endolysin gave a measurable increase in lytic activity on <i>B. subtilis</i> as has been previously described in the literature<sup>2</sup>. As seen in Figure 3, there is a substantial decrease in OD600 over time relative to the negative controls for CD27L, and a slight decrease in OD600 of <i>B. subtilis</i> for CD27L<sub>1-179</sub>. | ||
+ | |||
+ | [[File:BBa K3183200 vs BBa K3183201.png|thumb|center|700px|'''Figure 4:''' CD27L<sub>1-179</sub> Versus CD27L in Killing <i>B. subtilis</i><br>The truncated CD27L<sub>1-179</sub> shows decreased growth relative to the negative control; however, log-phase growth resumes after 150 minutes. | ||
+ | CD27L endolysin results in decreased growth during the first 100 minutes, and growth thereafter appears to be linear. This may point to inhibited log-phase growth in subsequent generations of <i>B. subtilis</i> following CD27L exposure.]] | ||
+ | |||
+ | [[File:BBa_K3183201_in_gel_ecoli.png|thumb|center|700px|'''Figure 4:''' Purification gel of CD27L<sub>1-179</sub> with SpyCatcher gel-shift assay. The purpose of this SDS-PAGE was to see after purification whether CD27L<sub>1-179</sub> is expressed and in the sample solution. The Spycatcher003-680 fluorophore can bind irreversibly to SpyTag by an isopeptide bond<sup>5</sup>, hence on the image we can see both SpyCatcher at around 19kDa and the SpyCatcher003-680 fused CD27L<sub>1-179</sub> at around 36kDa. Thus, we can confirm that our solution does contain CD27L<sub>1-179</sub>.]] | ||
+ | |||
+ | ==Part Improvement of BBa_K895004== | ||
+ | |||
+ | A fundamental crux of the ProQuorum system is the expression of the endolysin which is responsible for the actual lysis and consequent killing of the pathogenic <i>C. difficile</i>. Thus, there is a clear need for an endolysin that fulfills the criteria of being: | ||
+ | <br><b> | ||
+ | 1. optimally expressed <br> | ||
+ | 2. optimally secreted and <br> | ||
+ | 3. optimally effective against <i>C.difficile</i><br></b><br> | ||
+ | |||
+ | Thus, we redesigned the [https://parts.igem.org/BBa_K895005 BBa_K895005] part submitted by the 2012 Dundee iGEM team, which consists of: | ||
+ | <br><b> | ||
+ | 1. truncated form of the CD27L endolysin, shown to increase both efficacy and host range<sup>2</sup> <br> | ||
+ | 2. Type VI secretion protein derived from S. typhimurium <br> | ||
+ | 3. Hemagglutinin (HA) Tag for Western Blotting</b><br><br> | ||
+ | In contrast, our novel part [https://parts.igem.org/BBa_K3183200 BBa_KK3183200] (CD27L) encodes: <br> | ||
+ | <b><br> | ||
+ | 1. full-length form of the CD27L endolysin<br> | ||
+ | 2. SpyTag for purification, oligomerisation, and other SpyCatcher applications<br> | ||
+ | 3. 6-His tag for easy purification<br></b> | ||
+ | <br> | ||
+ | Incorporating both of these parts into pET28A, our expression vector, we planned on testing the relative efficacies of B.subtilis killing as per our killing assays. Thus, we followed our generic pipeline of: <br><b> | ||
+ | 1. transformation of both constructs into E.coli (BL21 (DE3)-RIPL Competent E.coli) <br> | ||
+ | 2. miniprep + sequencing to verify successful transformation <br> | ||
+ | 3. induction of expression with IPTG <br></b><br> | ||
+ | [[File:BBa_K895005_Construct_Oxford.png|thumb|left|405px|'''Figure 1.1:''' Dundee CD27L<sub>1-179</sub> Construct in pET28A]] | ||
+ | [[File:BBa_K3183200_Construct_Oxford.png|thumb|right|455px|'''Figure 1.2:''' 6His-SpyTag-CD27L Construct in pET28A]] | ||
+ | <br><br> | ||
+ | Thus, we sought out the endolysin in an existing part made by the 2012 iGEM Team Dundee. However, despite identical growth and induction conditions, expression of the Dundee 2012 iGEM endolysin was unsuccessful, even in triplicate, as shown in Figure 1. In contrast, expression of the CD27L_Assay part was successful and quantitatively verified via both mass spectrometry and BCA assay, as in the Results page.<br><br> | ||
+ | [[File:BBa K895004 Expression Gel.png|thumb|center|700px|'''Figure 2:''' Dundee CD27L<sub>1-179</sub> Expression Gel]] | ||
+ | <br><br> | ||
+ | Thus, to solve this issue, we decided to attempt expression of only the truncated endolysin from the Dundee 2012 Biobrick, without its substantially large Type VI secretion tag. We added 6His and SpyTag to the N-terminus to allow for detection (via SpyCatcher gel-shift assays) and purification. This resulted in CD27L<sub>1-179</sub> (<partinfo>BBa_K3183201</partinfo>). Upon analysis, there is evident expression of the truncated endolysin as seen in Figure 2. However, given identical conditions of growth and induction, there appears to be greater expression of the full-length endolysin, which may perhaps indicate greater stability.<br><br> | ||
+ | [[File:BBa_K31830012_Purification_Gel.png|thumb|center|700px|'''Figure 3:''' CD27L<sub>1-179</sub> Purification Gel]] | ||
+ | <br> | ||
+ | <br> | ||
+ | As a further improvement, we decided to measure the killing efficacy of the CD27L_Assay endolysin on <i>B. subtilis</i> (our surrogate target) as no killing data was provided for the Dundee 2012 BBa_K895005 part. As seen in Figure 3, there is a substantial decrease in OD600 over time relative to the negative controls.<br><br> | ||
+ | [[File:BBa K3183200 vs BBa K3183201.png|thumb|center|700px|'''Figure 4:''' CD27L<sub>1-179</sub> Versus CD27L in Killing <i>B. subtilis</i><br>The truncated CD27L<sub>1-179</sub> shows decreased growth relative to the negative control; however, log-phase growth resumes after 150 minutes. | ||
+ | CD27L endolysin results in decreased growth during the first 100 minutes, and growth thereafter appears to be linear. This may point to inhibited log-phase growth in subsequent generations of <i>B. subtilis</i> following CD27L exposure. | ||
+ | ]] | ||
+ | |||
+ | === Reference === | ||
+ | 1. Mayer, M. J., et al. “Molecular Characterization of a Clostridium Difficile Bacteriophage and Its Cloned Biologically Active Endolysin.” Journal of Bacteriology, vol. 190, no. 20, 2008, pp. 6734–6740., doi:10.1128/jb.00686-08.<br> | ||
+ | 2. Mayer, M. J et al. “Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range.” Journal of bacteriology vol. 193,19 (2011): 5477-86. doi:10.1128/JB.00439-11<br> | ||
+ | 3. Dunne, Matthew et al. “The CD27L and CTP1L endolysins targeting Clostridia contain a built-in trigger and release factor.” PLoS pathogens vol. 10,7 e1004228. 24 Jul. 2014, doi:10.1371/journal.ppat.1004228<br> | ||
+ | 4. Twetman, Svante, et al. “Scanning Electron Microscopic Study of Streptococcus Mutans BHT Lysed by Lysozyme.” European Journal of Oral Sciences, vol. 93, no. 1, 1985, pp. 23–29., doi:10.1111/j.1600-0722.1985.tb01304.x. | ||
+ | 5. Reddington, Samuel C., and Mark Howarth. “Secrets of a Covalent Interaction for Biomaterials and Biotechnology: SpyTag and SpyCatcher.” Current Opinion in Chemical Biology, vol. 29, Dec. 2015, pp. 94–99. DOI.org (Crossref), doi:10.1016/j.cbpa.2015.10.002. |
Latest revision as of 03:10, 22 October 2019
Truncated CD27L 1-179 with 6-His and SpyTag
This part contains CD27L fused to an N-Terminal 6-His Tag and SpyTag for purification, oligomerisation, and other SpyCatcher applications. This endolysin has previously been shown to be specific to C. difficile. This endolysin works by cleaving the bond between N-acetylmuramic acid and L-alanine1 (Fig. 1), breaking the cell's peptidoglycan and compromising the structural integrity of its cell wall. Two X-ray crystal structures were solved for the N-terminal domain2.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Characterisation
We expressed endolysin in the pET28A vector following difficulties with Dundee's CD27L1-179 endolysin BBa_K895005. We were able to achieve strong expression under the pET28A system (Fig. 3).
Due to safety concerns, our endolysin killing assays could only be carried out on on Bacillus subitlis, a Category 1 bacteria as opposed to Clostridium difficile, a Category 2 bacteria. B. subtilis has a similar composition of peptidogylcan cell wall to C. difficile2, allowing us to quantify killing data. We wanted to see if the truncated endolysin gave a measurable increase in lytic activity on B. subtilis as has been previously described in the literature2. As seen in Figure 3, there is a substantial decrease in OD600 over time relative to the negative controls for CD27L, and a slight decrease in OD600 of B. subtilis for CD27L1-179.
Part Improvement of BBa_K895004
A fundamental crux of the ProQuorum system is the expression of the endolysin which is responsible for the actual lysis and consequent killing of the pathogenic C. difficile. Thus, there is a clear need for an endolysin that fulfills the criteria of being:
1. optimally expressed
2. optimally secreted and
3. optimally effective against C.difficile
Thus, we redesigned the BBa_K895005 part submitted by the 2012 Dundee iGEM team, which consists of:
1. truncated form of the CD27L endolysin, shown to increase both efficacy and host range2
2. Type VI secretion protein derived from S. typhimurium
3. Hemagglutinin (HA) Tag for Western Blotting
In contrast, our novel part BBa_KK3183200 (CD27L) encodes:
1. full-length form of the CD27L endolysin
2. SpyTag for purification, oligomerisation, and other SpyCatcher applications
3. 6-His tag for easy purification
Incorporating both of these parts into pET28A, our expression vector, we planned on testing the relative efficacies of B.subtilis killing as per our killing assays. Thus, we followed our generic pipeline of:
1. transformation of both constructs into E.coli (BL21 (DE3)-RIPL Competent E.coli)
2. miniprep + sequencing to verify successful transformation
3. induction of expression with IPTG
Thus, we sought out the endolysin in an existing part made by the 2012 iGEM Team Dundee. However, despite identical growth and induction conditions, expression of the Dundee 2012 iGEM endolysin was unsuccessful, even in triplicate, as shown in Figure 1. In contrast, expression of the CD27L_Assay part was successful and quantitatively verified via both mass spectrometry and BCA assay, as in the Results page.
Thus, to solve this issue, we decided to attempt expression of only the truncated endolysin from the Dundee 2012 Biobrick, without its substantially large Type VI secretion tag. We added 6His and SpyTag to the N-terminus to allow for detection (via SpyCatcher gel-shift assays) and purification. This resulted in CD27L1-179 (BBa_K3183201). Upon analysis, there is evident expression of the truncated endolysin as seen in Figure 2. However, given identical conditions of growth and induction, there appears to be greater expression of the full-length endolysin, which may perhaps indicate greater stability.
As a further improvement, we decided to measure the killing efficacy of the CD27L_Assay endolysin on B. subtilis (our surrogate target) as no killing data was provided for the Dundee 2012 BBa_K895005 part. As seen in Figure 3, there is a substantial decrease in OD600 over time relative to the negative controls.
Reference
1. Mayer, M. J., et al. “Molecular Characterization of a Clostridium Difficile Bacteriophage and Its Cloned Biologically Active Endolysin.” Journal of Bacteriology, vol. 190, no. 20, 2008, pp. 6734–6740., doi:10.1128/jb.00686-08.
2. Mayer, M. J et al. “Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range.” Journal of bacteriology vol. 193,19 (2011): 5477-86. doi:10.1128/JB.00439-11
3. Dunne, Matthew et al. “The CD27L and CTP1L endolysins targeting Clostridia contain a built-in trigger and release factor.” PLoS pathogens vol. 10,7 e1004228. 24 Jul. 2014, doi:10.1371/journal.ppat.1004228
4. Twetman, Svante, et al. “Scanning Electron Microscopic Study of Streptococcus Mutans BHT Lysed by Lysozyme.” European Journal of Oral Sciences, vol. 93, no. 1, 1985, pp. 23–29., doi:10.1111/j.1600-0722.1985.tb01304.x.
5. Reddington, Samuel C., and Mark Howarth. “Secrets of a Covalent Interaction for Biomaterials and Biotechnology: SpyTag and SpyCatcher.” Current Opinion in Chemical Biology, vol. 29, Dec. 2015, pp. 94–99. DOI.org (Crossref), doi:10.1016/j.cbpa.2015.10.002.